claims of dietary supplement ingredients resulted in a lawsuit, Pearson v.
ENDO PHARMACEUTICALS MULTIVITAMIN LAWSUIT PLUS
Under the terms of the civil settlement, Qualitest will pay $39,000,000 to the states and federal governments, plus interest. To assist members and other advocates of the International Society of Sports. Idaho will receive $87,467 from the settlement.Īccording to the whistleblower lawsuit, Qualitest unlawfully labeled and marketed the tablets as containing the American Dental Association (ADA) recommended amount of fluoride, when in fact the tablets contained less than half that amount. The settlement resolves allegations of unlawful labeling practices involving Qualitest-branded multivitamin tablets with fluoride. Health Care, Pharmaceuticals and Medical Devices. appeals court to revive its lawsuit seeking to block Eagle Pharmaceuticals Inc from selling. According to a release from the Offices of District Attorneys General, the settlement has been approved after more than four years of litigation against U.S. Qualitest is a manufacturer of generic pharmaceutical products a wholly owned subsidiary of Endo Pharmaceuticals. The Mass Torts, Insurance and Consumer Litigation Group at Skadden has been involved in many of the. (Reuters) - Endo International's Par Pharmaceutical Inc on Wednesday failed to persuade a U.S. Attorney General Lawrence Wasden announced today that Idaho has joined 47 states and the federal government in a settlement agreement with Qualitest Pharmaceuticals.
0 kommentar(er)
